Skip to main content

Search

Types

News (183)
Video Asset (18)

Showing 49 - 72 of 201 results

Previous| 1... 2 | 3 | 4 ...9 |Next

Partin Stepping Down as Director

Partin Stepping Down as Director

Spotlight on UTUC

Spotlight on UTUC

Neoadjuvant Chemotherapy and Muscle-Invasive Bladder Cancer

Neoadjuvant Chemotherapy and Muscle-Invasive Bladder Cancer

Treatment Goals for NMIBC: What Do Patients Think?

Treatment Goals for NMIBC: What Do Patients Think?

Men and Women Respond Differently to Immune Checkpoint Blockade

Men and Women Respond Differently to Immune Checkpoint Blockade

New Guidance for Treating Early Testicular Cancer

New Guidance for Treating Early Testicular Cancer

Ultrasound and Testicular Tumors

Ultrasound and Testicular Tumors

“Unclassifiable” Kidney Cancer: New Insights

“Unclassifiable” Kidney Cancer: New Insights

RCC: Local Recurrence Can Be Cured with Surgery

RCC: Local Recurrence Can Be Cured with Surgery

Urogynecological Surgery Case Study—New Program’s Minimally Invasive Approach

Urogynecological Surgery Case Study—New Program’s Minimally Invasive Approach

Our Unique Approach to Female Urologic Reconstruction | Dr. Marisa Clifton

Our Unique Approach to Female Urologic Reconstruction | Dr. Marisa Clifton

JAMA Study: Immunotherapy May Affect Male Fertility

JAMA Study: Immunotherapy May Affect Male Fertility

Early-Stage Testicular Cancer: Treating with Surgery Alone?

Early-Stage Testicular Cancer: Treating with Surgery Alone?

Newly Discovered Cells Shed Light on Immunotherapy in Kidney Cancer

Newly Discovered Cells Shed Light on Immunotherapy in Kidney Cancer

The Hunt for Urinary Biomarkers to Diagnose Kidney Cancer

The Hunt for Urinary Biomarkers to Diagnose Kidney Cancer

Shedding Light on the “Trickle-Down” Effect of Mutated Genes in Kidney Cancer

Shedding Light on the “Trickle-Down” Effect of Mutated Genes in Kidney Cancer

Our Multidisciplinary Kidney Cancer Group

Our Multidisciplinary Kidney Cancer Group

If Bladder Cancer Responds Well to Chemotherapy, Is It Safe to Skip the Cystectomy?

If Bladder Cancer Responds Well to Chemotherapy, Is It Safe to Skip the Cystectomy?

Can Biomarkers Predict Who Will Benefit from Chemotherapy in Bladder Cancer?

Can Biomarkers Predict Who Will Benefit from Chemotherapy in Bladder Cancer?

Tackling a Rare, Aggressive Form of Cancer

Tackling a Rare, Aggressive Form of Cancer

New Immunotherapy Targets: B Cells

New Immunotherapy Targets: B Cells

Targeting Hypoxia in Bladder Cancer

Targeting Hypoxia in Bladder Cancer

Coulter Joins Research Faculty

Coulter Joins Research Faculty

Kidney Cancer Q&A

Kidney Cancer Q&A

Showing 49 - 72 of 201 results

Previous| 1... 2 | 3 | 4 ...9 |Next

Connect with Johns Hopkins Medicine

Join Our Social Media Communities >

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Powered by BROADCASTMED